August 28, 2017

There was no evidence of a leveling off of effect and no new safety concerns were identified in this analysis, Amgen reported.

August 23, 2017

Dr. Mark Sigro, who has been BioDelivery Sciences' president and CEO since 2005, will be retiring at the end of the year. 

August 22, 2017

The move potentially reduces the number of vials needed for hemophilia A patients and offers them more treatment options, the company said.

August 22, 2017

The site offers healthcare professionals tools that include an informational video, a guide on how to get started and a patient enrollment form.

August 18, 2017

The drug is indicated to treat adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia, or ALL.

August 18, 2017

WILMINGTON, Del. — AstaZeneca and Merck’s Lynzparza (olaparib) tablets were approved by the Food and Drug Administration, as well as given an expanded indication by the regulatory agency.

August 10, 2017

In clinical trials, 33% of patients treated with Radicava showed a lower rate of decline in the loss of physical function, compared with those on a placebo.

August 7, 2017

The company said it’s the only FDA-approved liquid dosage form of potassium-sparing diuretic spironolactone.

August 7, 2017
The QVAR RediHaler is a breath-actuated inhaler for the maintenance of asthma as a prophylactic treatment in patients ages 4 years and older.
August 4, 2017

Vyxeos combines two commonly used chemotherapies into a single formulation to treat patients with certain types of high-risk acute myeloid leukemia. 

August 4, 2017

The single-tablet hepatitis C regimen is now approved for use in patients with hepatitis C that are co-infected with HIV.

August 3, 2017

The drug received priority review and breakthrough therapy designations, as well as orphan drug designation for this indication.

August 3, 2017
The FDA said that Mavyret is the first treatment of eight-week duration for all hepatitis C genotypes.
August 3, 2017

The bill contains the reauthorizations of the Food and Drug Administration’s Prescription Drug, Biosimilar, and Generic Drug User Fee Acts.

August 2, 2017

In addition to rolling out new value-focused initiatives, CVS Health said it would be removing 17 drugs from its Standard Control Formulary in 2018 

August 2, 2017
The new indication is for use in more than 600 people with cystic fibrosis ages 2 years and older who have one of five residual function mutations.
August 1, 2017

The National Cancer Institute at the National Institutes of Health estimates that roughly 21,380 people will be diagnosed with acute myeloid leukemia this year, and estimates that it will kill 10,590 patients in 2017.

July 31, 2017
The drug, approved by the Food and Drug Administration in April, is indicated to treat acute lymphoblastic leukemia and manage polyarticular juvenile idiopathic arthritis in pediatric patients.
July 27, 2017

Fycompa is the first antiepileptic drug to apply FDA's regulatory pathway of extrapolation for monotherapy use.

July 26, 2017

As chief information officer for Walmart, GSK's new chief digital & technology officer led a multi-year effort to transform Walmart in the use of data, analytics and digital engagement with its customers.

July 20, 2017

Gilead’s hepatitis C treatment Vosevi and Puma Biotechnology’s breast cancer drug Nerlynx both earned Food and Drug Administration approval this week. 

July 17, 2017

CVS Health president and CEO Larry Merlo made the announcement alongside Rhode Island Gov. Gina Raimondo at the 2017 National Governor’s Association Summer Meeting, where Merlo has been touting the company’s approach to providing accessible and effective care.

July 14, 2017

Tremfya (guselkumab) is the first drug to be approved that selectively blocks a key plaque psoriasis cytokine, the company said.

July 14, 2017

Mike Hotra joins the organization as VP of its public affairs team, and Ken McKay is the advocacy organization’s new VP state government affairs.